Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis

International Journal of Molecular Medicine

Volumn 24, Issue 6, 2009, Pages 743-747

  Proia, Patrizia ^a   Schiera, Gabriella ^a   Salemi, Giuseppe ^a   Ragonese, Paolo ^a   Savettieri, Giovanni ^a   Di Liegro, Italia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Brain cell cultures; In vitro models of blood brain barrier; Multiple sclerosis; Neuronal cell death; Transendothelial electrical resistance

Indexed keywords

OCCLUDIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER DAMAGE; CELL ISOLATION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; ELECTRIC RESISTANCE; FETUS; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; MEMBRANE PERMEABILITY; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NERVOUS SYSTEM INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RAT; SERUM FACTOR; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; ELECTRIC IMPEDANCE; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICROSCOPY, PHASE-CONTRAST; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEURONS; RATS; RATS, WISTAR;

EID: 70350778322     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000287     Document Type: Article

References (33)

1. Brassat D and Oksenberg JR: Genetics of multiple sclerosis. In: Molecular Bases of Neurodegeneration. Di Liegro I and Savettieri G (ed). Research Signpost, Kerala, pp43-59, 2005.
2. Olsson T, Jagodic M, Piehl F and Wallstrom E: Genetics of autoimmune neuroinflammation. Curr Opin Immunol 18: 643-649, 2006.
3. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M and Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717, 2000.
4. Steinman L: Multiple sclerosis: a two-stage disease. Nat Immunol 2: 762-764, 2001.
5. van Horssen J, Bo L, Dijkstra CD and de Vries HE: Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol Dis 24: 484-491, 2006.
6. McQualter JL and Bernard CCA: Multiple sclerosis: a battle between destruction and repair. J Neurochem 100: 295-306, 2007.
7. Ferguson B, Matyszak MK, Esiri MM and Perry VH: Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399, 1997.
8. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J and Bruck W: Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125: 2202-2212, 2002.
9. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH and Song SK: Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21: 626-632, 2006.
10. Bjartmar C, Wujek JR and Trapp BD: Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206: 165-171, 2003.
11. Malmestrom C, Haghighi S, Rosengren MD, Andersen O and Lycke J: Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurobiology 61: 1720-1725, 2003.
12. Alcazar A, Regidor I, Masjuan J, Salinas M and Alvarez- Cermeno JC: Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 104: 58-67, 2000.
13. Oren A, White L and Aasly J: Apoptosis in neurons exposed to cerebrospinal fluid from patients with multiple sclerosis or acute polyradiculoneuropathy. J Neurol Sci 186: 31-36, 2001.
14. Peterson JW, Bo L, Mork S, Chang A and Trapp BD: Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50: 389-400, 2001.
15. Meyer R, Weissert R, Diem R, Storch MK, de Graaf KL, Kramer B and Bahr M: Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci 21: 6214-6220, 2001.
16. Leech S, Kirk J, Plumb J and McQuaid S: Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 33: 86-98, 2007.
17. Tanuma N, Sakuma H, Sasaki A and Matsumoto Y: Chemokine expression by astrocytes play a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol 112: 195-204, 2006.
18. Proia P, Schiera G, Mineo M, Ingrassia AM, Santoro G, Savettieri G and Di Liegro I: Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. Int J Mol Med 21: 63-67, 2008.
19. Cestelli A, Savettieri G, Ferraro D and Vitale F: Formulation of a novel synthetic medium for selectively culturing rat CNS neurons. Dev Brain Res 22: 219-227, 1987.
20. Savettieri G, Licata L, Catania C, Raneri R, Di Liegro I and Cestelli A: Synergistic effects of laminin and thyroid hormones on neuron polarity in culture. Neurol Rep 10: 1269-1272, 1999.
21. Cole R and de Vellis J: A Dissection and Tissue Culture Manual of the Nervous System. Alan R. Liss Inc., New York, 1989.
22. Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, Borre JM, Strosberg AD and Courad PO: Regulation of gammaglutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 159: 101-113, 1994.
23. Schiera G, Bono E, Raffa MP, Gallo A, Pitarresi GL, Di Liegro I and Savettieri G: Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. J Cell Mol Med 7: 165-170, 2003.
24. Schiera G, Sala S, Gallo A, Raffa MP, Pitarresi GL, Savettieri G and Di Liegro I: Permeability properties of a three-cell type in vitro model of blood-brain barrier. J Cell Mol Med 9: 373-379, 2005.
25. Schiera G and Proia P: In vitro models of blood-brain barrier: formation and functioning. In: Molecular Bases of Neurodegeneration. Di Liegro I and Savettieri G (ed). Kerala, pp183-197, 2005.
26. Schiera G, Proia P, Alberti C, Mineo M, Savettieri G and Di Liegro I: Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular veiscles. J Cell Mol Med 11: 1384-1394, 2007.
27. Savettieri G, Di Liegro I, Catania C, Licata L, Pitarresi GL, D'Agostino S, Schiera G, De Caro V, Giandalia G, Giannola LI and Cestelli A: Neurons and ECM regulate occludin localization in brain endothelial cells. Neurol Rep 11: 1081-1084, 2000.
28. Cestelli A, Catania C, D'Agostino S, Di Liegro I, Licata L, Schiera G, Pitarresi GL, Savettieri G, De Caro V, Giandalia G and Giannola LI: Functional features of a novel model of Blood Brain Barrier: studies on permeation of test compounds. J Control Release 76: 139-147, 2001.
29. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY and Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127, 2001.
30. Chen YH, Marzdorf C, Paul DL and Goodenough DA: COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryo. J Cell Biol 138: 891-899, 1997.
31. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S and Tsukita S: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123: 1777-1788, 1993.
32. Kwon EE and Prineas JW: Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J Neuropath Exp Neurol 53: 625-636, 1994.
33. Bruck W, Bitsch A, Kolenda H, Brück Y, Stiefel M and Lassmann H: Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42: 783-793, 1997.